Position in AMGN
as of Jun 30, 2026
· filed Aug 5, 2026
Position Value
$3,079,830
+$112,679 QoQ
Shares Held
8,505
+0.9% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
#1,065
of 3,149 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in AMGN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Fort Sheridan Advisors LLC holds $58,603,256 across 10 Drug Manufacturers - General names. AMGN ranks #5 (5.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
68,432 | $17,220,228 | |
| 2 | JNJ |
Johnson & Johnson
|
50,589 | $12,848,088 | |
| 3 | MRK |
Merck & Co., Inc.
|
98,070 | $12,601,995 | |
| 4 | LLY |
ELI LILLY & Co
|
5,314 | $6,373,771 | |
| 5 | AMGN |
Amgen Inc
This page
|
8,505 | $3,079,830 | |
| 6 | PFE |
Pfizer Inc
|
120,987 | $2,913,366 | |
| 7 | NVS |
Novartis AG
|
13,967 | $2,188,908 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
4,810 | $607,695 |
All Filings in AMGN
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $3,079,830 | 8,505 | Shares | Sole | 2026-08-05 | |
| 2026-03-31 | $2,967,151 | 8,433 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $2,344,848 | 7,164 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $1,945,769 | 6,895 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,888,018 | 6,762 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,164,337 | 6,947 | Shares | Sole | 2025-05-01 | |
| 2024-12-31 | $1,766,617 | 6,778 | Shares | Sole | 2025-02-05 | |
| 2024-09-30 | $1,888,795 | 5,862 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $1,805,961 | 5,780 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $1,222,291 | 4,299 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $1,071,434 | 3,720 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $986,349 | 3,670 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $626,096 | 2,820 | Shares | Sole | 2023-08-01 | |
| 2023-03-31 | $470,687 | 1,947 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $505,844 | 1,926 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $434,120 | 1,926 | Shares | Sole | 2022-11-09 | |
| 2022-06-30 | $458,620 | 1,885 | Shares | Sole | 2022-08-08 | |
| 2022-03-31 | $293,811 | 1,215 | Shares | Sole | 2022-05-09 | |
| 2021-12-31 | $276,938 | 1,231 | Shares | Sole | 2022-02-10 | |
| 2021-09-30 | $398,293 | 1,873 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $461,175 | 1,892 | Shares | Sole | 2021-08-17 | |
| 2021-03-31 | $468,011 | 1,881 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $432,479 | 1,881 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $478,074 | 1,881 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $442,237 | 1,875 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $384,578 | 1,897 | Shares | Sole | 2020-05-12 | |
| No filing history on record for this holder in this stock. | ||||||